The seismic breakthroughs in science and medicine — and the challenges that lie ahead for scientific institutions and health care systems — took center stage at our 2021 STAT Summit. The event featured perspectives from biotech visionaries like George Church, top executives at GlaxoSmithKline and Verily, and the minds behind the Biden administration’s ARPA-H program. It also looked deeply at both the crisis of Black maternal mortality in the U.S., the future of treatment for Alzheimer’s disease, and the next stage of drug pricing legislation in Congress.
Taken together, these stories underscore the important conversations that are taking place, as researchers, health care industry leaders, and policymakers navigate the future of science and medicine. We hope this eBook presents a useful exploration of these concepts in the year to come.
Publication date: January 2022
Print length: 53 pages
File size: 5 MB
File format: PDF
Language: English
Enter the information below to begin your free e-book download
About the sponsor
About the sponsor
Genentech’s journey started with a big question: Can genetic engineering technology revolutionize medicine? What seemed improbable – or at least very premature – at the time soon became the ambitious goal of our founders, the mission of our company, and the beginning of the biotechnology industry.
More than four decades later, the answer to that question – and to the countless others that followed it – has transformed and extended the lives of so many patients with serious and life-threatening medical conditions.
But as long as people continue to suffer from diseases like cancer, multiple sclerosis and Alzheimer’s, there is still much more to do. And the obstacles that remain are arguably the toughest ones to overcome.
We believe the opportunity for the greatest impact starts with the challenge set by the boldest question. So today we’re pushing even harder and asking even bigger questions of ourselves, our industry and society. How can we ensure that all patients benefit from medical innovation? How can we advance from treating to curing, or even reversing the impact of disease? How can we intervene in early childhood to address traumas that can lead to serious illnesses later in life?
We’re passionate about finding the answers to all of these and more – both in the work we do and through critical partnerships and collaborations beyond our walls. Join us in examining some of the biggest questions in healthcare.